home | contact | pubmed search | Keyword Search:
ImmuneDisease.com logo Patients & FamiliesHealthcare ProfessionalsGAMMAGARD

GAMMAGARD GARDian

gardian

The GARDian program helps ensure patients' continued access to GAMMAGARD therapy.

GARDian is an innovative Baxter program designed to help ensure continued access to GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)] 10% and GAMMAGARD S/D [Immune Globulin Intravenous (Human)] for current patients. Enrolling your patients in GARDian is a simple, secure way to ensure their continued access to GAMMAGARD, their choice of treatment, when they change physician, site of care, or residence.

Using a simple, voluntary enrollment process administered through patients’ healthcare providers, enrollees will have the comfort of knowing that GAMMAGARD LIQUID and GAMMAGARD S/D will be available to them today and tomorrow.

Sign up to receive updates on the GARDian program.

Visit MyGARDian.com for more information about this program.

 

This site is intended for use only by residents of the United States. Copyright © 2005-2008, Baxter Healthcare Corporation. All rights reserved.